About R.K. Laboratories Private Limited
Data last updated:
R.K. Laboratories Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 May 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH2007PTC030809. Its GSTIN is 02AADCR7154G2ZK (Himachal Pradesh). The company holds 4 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹5.32 Cr. It is led by directors Ashwani Gupta and Abhinav Gupta.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at House No. 218 Sector 9, Chandigarh, India – 160009.
As per the financials filed for FY 2024, the company reported a revenue of ₹47.96 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹2.06 Cr (net margin 4.3%) and EBITDA of ₹7.03 Cr (EBITDA margin 14.7%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 12% over five years.
The company has about 114 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹72.31 Cr and satisfied charges of ₹65.82 Cr on record. Court records list 33 cases involving the company, including 5 filed by the company and 26 filed against it; 12 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rklaboratories.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressHouse No. 218 Sector 9, Chandigarh, India – 160009
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of R.K. Laboratories Private Limited
The main business activity of R.K. Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of R.K. Laboratories Private Limited FY 2024 filings available
R.K. Laboratories Private Limited reported revenue of ₹47.96 Cr (up 10% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of R.K. Laboratories Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 10% growth in the latest year. EBITDA rose 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of R.K. Laboratories Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹7.03 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.06 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of R.K. Laboratories Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of R.K. Laboratories are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of R.K. Laboratories Private Limited
R.K. Laboratories Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sainor Pharma Private Limited | ₹48.47 Cr (FY 2016) | •••• | •••• | 0.0% | •••• | Hyderabad, Telangana, India |
| Glow Pharma Private Limited | ₹48.18 Cr (FY 2025) | •••• | •••• | 23.0% | •••• | Mumbai, Maharashtra, India |
| Rhydburg Pharmaceuticals Ltd | ₹48.17 Cr (FY 2024) | •••• | •••• | 26.0% | •••• | Delhi, India |
| Edkem Pharmaceuticals Limited | ₹48.11 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Ahmedabad, Gujarat, India |
| Indasi Lifescience Private Limited | ₹48.01 Cr (FY 2025) | •••• | •••• | 25.0% | •••• | Daman, Daman and Diu, India |
| R.K. Laboratories Private Limited this company | ₹47.96 Cr (FY 2024) | •••• | •••• | 10.0% | •••• | Chandigarh, India |
| Biddle Sawyer Limited | ₹47.93 Cr (FY 2025) | •••• | •••• | -28.0% | •••• | Mumbai, Maharashtra, India |
| Goddres Pharmaceuticals Private Limited | ₹47.78 Cr (FY 2024) | •••• | •••• | 9.0% | •••• | Mumbai, Maharashtra, India |
| Vineet Laboratories Private Limited | ₹47.5 Cr (FY 2010) | •••• | •••• | 34.0% | •••• | Hyderabad, Telangana, India |
| Mendine Pharmaceuticals Pvt Ltd | ₹47.44 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Kolkata, West Bengal, India |
| Linux Life Sciences Private Limited | ₹47.4 Cr (FY 2025) | •••• | •••• | 52.0% | •••• | Puducherry, India |
Peers are the five companies nearest above and the five nearest below R.K. Laboratories by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of R.K. Laboratories Private Limited
R.K. Laboratories Private Limited is audited by VINOD KUMAR & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| VINOD KUMAR & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of R.K. Laboratories Private Limited
R.K. Laboratories has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashwani Gupta | Director | 09 May 2007 | 19 Years 4 Months | Current |
| Abhinav Gupta | Director | 09 May 2007 | 19 Years 4 Months | Current |
Ownership and Shareholding of R.K. Laboratories Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of R.K. Laboratories Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Feb 2025 | Hdfc Bank Limited | ₹2.23 Cr | Open |
| 16 Apr 2024 | Hdfc Bank Limited | ₹20.07 Lakh | Open |
| 29 Aug 2023 | Hdfc Bank Limited | ₹10.2 Lakh | Open |
| 20 Jul 2021 | Hdfc Bank Limited | ₹96.85 Lakh | Open |
| 24 Jul 2020 | Hdfc Bank Limited | ₹68.81 Cr | Open |
Total charge records: 11 View all charges
Legal Cases of R.K. Laboratories Private Limited
R.K. Laboratories Private Limited has 33 court cases on record: 5 filed by R.K. Laboratories, 26 filed against it, 2 where it is another party. 12 cases are pending and 21 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 29 | 25 | 11 |
| High courts | 4 | 1 | 1 |
Cases on record (5 of 33)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Interim or miscellaneous application | Filed against the company by Machinfabrik Industries Private Limited | Disposed |
| District court, Chandigarh | Cheque dishonour complaint | Filed against the company by Tata Capital Financial Services Limited | Disposed |
| District court, UTTARA KANNADA, Karnataka | Criminal complaint | Filed against the company by M.N.Chemicals Limited | Disposed |
| District court, Faridabad, Haryana | Civil suit | Filed against the company by Sierra Pharmaceuticals Limited. | Disposed |
| District court, SAS Nagar, Punjab | Cheque dishonour complaint | Filed against the company by B.S Company | Pending |
Full case history
All 33 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at R.K. Laboratories Private Limited
R.K. Laboratories Private Limited has a workforce of 114 employees as of Apr 09, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on R.K. Laboratories Private Limited
R.K. Laboratories Private Limited has 3 board changes on record since 2007: 2 appointments and 1 cessation. The latest: Manjulla Gupta ceased to be Director on 19 May 2011.
14 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for R.K. Laboratories Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by R.K. Laboratories Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of R.K. Laboratories Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of R.K. Laboratories Private Limited
R.K. Laboratories has 4 GST registrations: 1 active and 3 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AADCR7154G2ZK | Himachal Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of R.K. Laboratories Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about R.K. Laboratories Private Limited
R.K. Laboratories is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 May 2007 (19+ years old) and is registered under CIN U24232CH2007PTC030809.
R.K. Laboratories reported revenue of ₹47.96 Cr for FY 2024 (up 10% YoY).
R.K. Laboratories has 2 current directors:
- Ashwani Gupta - Director
- Abhinav Gupta - Director
R.K. Laboratories reported a net profit of ₹2.06 Cr (net margin 4.3%) and EBITDA of ₹7.03 Cr (EBITDA margin 14.7%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of R.K. Laboratories is 21% over three years and 12% over five years. In the latest year (FY 2024) revenue rose 10%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of R.K. Laboratories is 02AADCR7154G2ZK, registered in Himachal Pradesh. The company has 4 GST registrations in all, of which 1 is active and 3 are cancelled or inactive.
The CIN (Corporate Identification Number) of R.K. Laboratories is U24232CH2007PTC030809. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
R.K. Laboratories has 33 court cases on record: 5 filed by the company and 26 filed against it. 12 are pending. Most are in the district courts.
R.K. Laboratories was incorporated on 09 May 2007, making it 19+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of R.K. Laboratories by revenue are Sainor Pharma Private Limited, Glow Pharma Private Limited, Rhydburg Pharmaceuticals Ltd, Edkem Pharmaceuticals Limited, Indasi Lifescience Private Limited and 5 more, all in the Pharma industry (Formulations).
Manjulla Gupta ceased to be Director on 19 May 2011. Abhinav Gupta was appointed as Director on 09 May 2007. Ashwani Gupta was appointed as Director on 09 May 2007.